RN7SL143P

Across TCGA pan-cancer cohorts, RN7SL143P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RN7SL143P data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher RN7SL143P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL143P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

DLBC, BLCA, and SKCM are the cancer types where RN7SL143P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	All	0.144	0.800	.003	79	view →
BLCA	DFS	Tertile	IV	0.071	0.485	<.001	27	view →
SKCM	DFS	Tertile	III,IV	0.182	0.604	.008	18	view →
ESCA	DFS	Tertile	III,IV	0.584	0.260	.025	15	view →
SARC	OS	Tertile	All	0.194	0.521	.044	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RN7SL143P–DLBC (OS)

Open the DLBC breakdown →